These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 38450549)
1. The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study. Parksook WW; Brown JM; Omata K; Tezuka Y; Ono Y; Satoh F; Tsai LC; Niebuhr Y; Milks J; Moore A; Honzel B; Liu H; Auchus RJ; Sunthornyothin S; Turcu AF; Vaidya A J Clin Endocrinol Metab; 2024 Aug; 109(9):2220-2232. PubMed ID: 38450549 [TBL] [Abstract][Full Text] [Related]
2. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859 [TBL] [Abstract][Full Text] [Related]
3. The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. Brown JM; Siddiqui M; Calhoun DA; Carey RM; Hopkins PN; Williams GH; Vaidya A Ann Intern Med; 2020 Jul; 173(1):10-20. PubMed ID: 32449886 [TBL] [Abstract][Full Text] [Related]
4. Continuum of Renin-Independent Aldosteronism in Normotension. Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182 [TBL] [Abstract][Full Text] [Related]
5. Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. Takeda Y; Umakoshi H; Takeda Y; Yoneda T; Kurihara I; Katabami T; Ichijo T; Wada N; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Takahashi K; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamto K; Ogo A; Yanase T; Suzuki T; Naruse M; J Hypertens; 2019 May; 37(5):1077-1082. PubMed ID: 30601318 [TBL] [Abstract][Full Text] [Related]
6. Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism. St-Jean M; Bourdeau I; Martin M; Lacroix A J Clin Endocrinol Metab; 2021 Jan; 106(1):e45-e60. PubMed ID: 33000146 [TBL] [Abstract][Full Text] [Related]
8. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism. Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182 [TBL] [Abstract][Full Text] [Related]
9. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach. Vaidya A; Carey RM J Clin Endocrinol Metab; 2020 Dec; 105(12):3771-83. PubMed ID: 32865201 [TBL] [Abstract][Full Text] [Related]
10. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism. Gill JR; Bartter FC J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487 [TBL] [Abstract][Full Text] [Related]
11. Severe hydronephrosis complicated with primary aldosteronism: a case report and review of the literature. Sun J; Zeng Q; Lai L; Gu M; Liu D; Wu G; Peng C; Yang S; Li Q; Lu J J Med Case Rep; 2024 Oct; 18(1):463. PubMed ID: 39369228 [TBL] [Abstract][Full Text] [Related]
12. Primary aldosteronism due to unilateral adrenal hyperplasia. Ganguly A; Zager PG; Luetscher JA J Clin Endocrinol Metab; 1980 Nov; 51(5):1190-4. PubMed ID: 6252233 [TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism. Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084 [TBL] [Abstract][Full Text] [Related]
14. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling for the subtyping of primary aldosteronism: a prospective study. Yang F; Wang Y; Zhang Z; Zeng Y; Liu M; Tian Z; Li P J Hypertens; 2024 Jun; 42(6):1019-1026. PubMed ID: 38527056 [TBL] [Abstract][Full Text] [Related]
15. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study. Brown JM; Robinson-Cohen C; Luque-Fernandez MA; Allison MA; Baudrand R; Ix JH; Kestenbaum B; de Boer IH; Vaidya A Ann Intern Med; 2017 Nov; 167(9):630-641. PubMed ID: 29052707 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213 [TBL] [Abstract][Full Text] [Related]
17. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism. Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781 [TBL] [Abstract][Full Text] [Related]
18. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]